Related Experiment Video
Updated: Sep 29, 2026

The Use of a β-lactamase-based Conductimetric Biosensor Assay to Detect Biomolecular Interactions
Published on: February 1, 2018
Acyl-intermediate structures of the extended-spectrum class A beta-lactamase, Toho-1, in complex with cefotaxime,
Tatsuro Shimamura1, Akiko Ibuka, Shinya Fushinobu
1Department of Biotechnology, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan.
Abstract:
Bacterial resistance to beta-lactam antibiotics is a serious problem limiting current clinical therapy. The most common form of resistance is the production of beta-lactamases that inactivate beta-lactam antibiotics. Toho-1 is an extended-spectrum beta-lactamase that has acquired efficient activity not only to penicillins but also to cephalosporins including the expanded-spectrum cephalosporins that were developed to be stable in former beta-lactamases. We present the acyl-intermediate structures of Toho-1 in complex with cefotaxime (expanded-spectrum cephalosporin), cephalothin (non-expanded-spectrum cephalosporin), and benzylpenicillin at 1.8-, 2.0-, and 2.1-A resolutions, respectively. These structures reveal distinct features that can explain the ability of Toho-1 to hydrolyze expanded-spectrum cephalosporins. First, the Omega-loop of Toho-1 is displaced to avoid the steric contacts with the bulky side chain of cefotaxime. Second, the conserved residues Asn(104) and Asp(240) form unique interactions with the bulky side chain of cefotaxime to fix it tightly. Finally, the unique interaction between the conserved Ser(237) and cephalosporins probably helps to bring the beta-lactam carbonyl group to the suitable position in the oxyanion hole, thus increasing the cephalosporinase activity.
Insights
Toho-1 beta-lactamase efficiently degrades advanced cephalosporin antibiotics. Structural analysis reveals unique adaptations in Toho-1, including an Omega-loop displacement and specific residue interactions, explaining its broad-spectrum resistance mechanism.
Area of Science:
- Biochemistry
- Structural Biology
- Microbiology
Background:
- Bacterial resistance to beta-lactam antibiotics poses a significant clinical challenge.
- Beta-lactamases are the primary mechanism by which bacteria inactivate these drugs.
- Extended-spectrum beta-lactamases (ESBLs) like Toho-1 confer resistance to a wide range of beta-lactam antibiotics, including newer cephalosporins.
Purpose of the Study:
- To elucidate the structural basis for the extended-spectrum activity of the Toho-1 beta-lactamase.
- To understand the molecular mechanisms by which Toho-1 hydrolyzes expanded-spectrum cephalosporins.
Main Methods:
- X-ray crystallography was used to determine the acyl-intermediate structures of Toho-1.
- Structures were solved in complex with cefotaxime, cephalothin, and benzylpenicillin at high resolutions (1.8–2.1 Å).
Main Results:
- The Omega-loop of Toho-1 undergoes displacement to accommodate the bulky side chain of cefotaxime.
- Conserved residues Asn(104) and Asp(240) form specific interactions that tightly bind the cefotaxime side chain.
- A unique interaction involving Ser(237) positions the beta-lactam carbonyl group for efficient hydrolysis, enhancing cephalosporinase activity.
Conclusions:
- The structural features of Toho-1, including Omega-loop flexibility and specific residue interactions, explain its ability to hydrolyze expanded-spectrum cephalosporins.
- Understanding these resistance mechanisms is crucial for developing new antibiotics and combating antimicrobial resistance.
More Related Videos
Related Concept Videos
Inhibitors of Gram-positive Cell Wall Synthesis
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Production of Antibiotics
Bacterial Toxins
Inhibitors of Bacterial Protein Synthesis

